Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Magalon

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Stem Cell Research & Therapy|December 19, 2014
New fat-derived products for treating skin-induced lesions of scleroderma in nude miceNicolas Serratrice, Laurie Bruzzese, Jérémy Magalon, et al.
Scientific Reports|February 20, 2026
First comparison of commercial systems to prepare nanofat: technical performances and biological quality differ among obtained productsRobin Arcani, Maxime Abellan, Stéphanie Simoncini, et al.
Annals of the Rheumatic Diseases|August 13, 2014
Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trialBrigitte Granel, Aurélie Daumas, Elisabeth Jouve, et al.
Facial Plastic Surgery & Aesthetic Medicine|April 18, 2025
Nanofat Use in Regenerative Medicine: A Systematic Literature Review and Consensus Recommendations from Expert OpinionsRobin Arcani, Mélanie Velier, Florence Sabatier, et al.
Stem Cell Research & Therapy|July 2, 2021
Inter-center comparison of good manufacturing practices-compliant stromal vascular fraction and proposal for release acceptance criteria: a review of 364 productionsPauline François, Giulio Rusconi, Laurent Arnaud, et al.
Rheumatology (Oxford, England)|July 23, 2021
Adipose tissue-derived stromal vascular fraction for treating hands of patients with systemic sclerosis: a multicentre randomized trial Autologous AD-SVF versus placebo in systemic sclerosisAurélie Daumas, Jérémy Magalon, Elisabeth Jouve, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Stem Cell Research & Therapy|December 19, 2014
New fat-derived products for treating skin-induced lesions of scleroderma in nude miceNicolas Serratrice, Laurie Bruzzese, Jérémy Magalon, et al.
Scientific Reports|February 20, 2026
First comparison of commercial systems to prepare nanofat: technical performances and biological quality differ among obtained productsRobin Arcani, Maxime Abellan, Stéphanie Simoncini, et al.
Annals of the Rheumatic Diseases|August 13, 2014
Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trialBrigitte Granel, Aurélie Daumas, Elisabeth Jouve, et al.
Facial Plastic Surgery & Aesthetic Medicine|April 18, 2025
Nanofat Use in Regenerative Medicine: A Systematic Literature Review and Consensus Recommendations from Expert OpinionsRobin Arcani, Mélanie Velier, Florence Sabatier, et al.
Stem Cell Research & Therapy|July 2, 2021
Inter-center comparison of good manufacturing practices-compliant stromal vascular fraction and proposal for release acceptance criteria: a review of 364 productionsPauline François, Giulio Rusconi, Laurent Arnaud, et al.
Rheumatology (Oxford, England)|July 23, 2021
Adipose tissue-derived stromal vascular fraction for treating hands of patients with systemic sclerosis: a multicentre randomized trial Autologous AD-SVF versus placebo in systemic sclerosisAurélie Daumas, Jérémy Magalon, Elisabeth Jouve, et al.
Pageof 5